~~<i id='6098D6BB60'><strike id='6098D6BB60'><tt id='6098D6BB60'><pre id='6098D6BB60'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

fashion

author：leisure time 2025-08-21 08:26:55 - browse：5486

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： This gene therapy has record $4.25 million price. It's saved children.

explore

focus

hotspot

Wikipedia

leisure time

explore

GeorgeYancopoulosonthe2024BreakthroughSummitEaststageSTATGeorgeYancopoulosisintouchwithhisteenagesel

WSS

A rare thyroid diagnosis led to unexpected, all

NIH nominee Bertagnolli will get October confirmation hearing

Stem cell treatment guidelines are released by FDA

Texas board proposes rules on abortion law emergency exemption

Medicare Advantage insurers pressure Biden for bigger payments

'Make People Better': The CRISPR babies story you probably don't know

Wikipedia

fashion

explore

After affirmative action ruling, medical educators look to 'holistic review'

AstraZeneca chief proposes a novel edit to the drug pricing bill

Cancer drug shortages should be causing more outrage

Asbestos ban is immediate, but health effects will linger for decades

Novavax promises a turnaround & Lilly roils the obesity market

How to protect patients from sexual assault

Affirmative action in medical school literally saved lives

Why Novartis is changing the name of its research labs

Medical records are filled with copy

Adam's Take: Intra

focus

Ethical issues complicate the benefits of medical crowdfunding

Biotech investment managers search for lucrative opportunities

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

NIH nominee Bertagnolli will get October confirmation hearing

Medicare Advantage insurers pressure Biden for bigger payments

Ethical issues complicate the benefits of medical crowdfunding

hotspot

Wikipedia

leisure time

explore